| Stage | MATX | % of rev | RCL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $969M | 100.00% | $5.6B | 100.00% | RCL ×5.77 |
| Gross profit | $232M | 23.94% | $2.9B | 51.51% | RCL +27.6pp |
| Operating income | $159M | 16.39% | $1.9B | 33.46% | RCL +17.1pp |
| Pre-tax income | $164M | 16.91% | $1.8B | 31.51% | RCL +14.6pp |
| Net income | $129M | 13.35% | $1.7B | 31.03% | RCL +17.7pp |
| Stage | MATX | RCL | Gap · A − B |
|---|---|---|---|
| Revenue | $969M100.00% | $5.6B100.00% | RCL ×5.77 |
| Gross profit | 23.94%$232M | 51.51%$2.9B | RCL +27.6pp |
| Operating income | 16.39%$159M | 33.46%$1.9B | RCL +17.1pp |
| Pre-tax income | 16.91%$164M | 31.51%$1.8B | RCL +14.6pp |
| Net income |
| 13.35%$129M |
| 31.03%$1.7B |
| RCL +17.7pp |
No disclosed counterparties: MATX, RCL.